ATC Group: J01FA09 Clarithromycin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J01FA09 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J01 Antibacterials for systemic use
3 J01F Macrolides, lincosamides and streptogramins
4 J01FA Macrolides
5 J01FA09 Clarithromycin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 0.5 g
PAREN - Parenteral 1 g

Active ingredients in J01FA09

Active Ingredient Description
Clarithromycin

Clarithromycin is a semi-synthetic derivative of erythromycin A. It exerts its antibacterial action by selectively binding to the 50s ribosomal sub-unit of susceptible bacteria preventing translocation of activated amino acids. It inhibits the intracellular protein synthesis of susceptible bacteria.

Related product monographs

Title Information Source Document Type  
CLAREM Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
CLARITHROMYCIN Film-coated tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CLARITHROMYCIN Powder for concentrate for solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CLERON Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
KLACID Film-coated tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
Klaricid 250mg Tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
KLERIMED Film coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicines in this ATC group

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Finland (FI)

France (FR)

Germany (DE)

Israel (IL)

Japan (JP)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.